<DOC>
	<DOCNO>NCT02764268</DOCNO>
	<brief_summary>Apatinib dose titration Advanced Metastatic Gastric Cancer</brief_summary>
	<brief_title>Apatinib Dose Titration Advanced Metastatic Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>1 . ≥ 18 ≤ 70 year age 2 . Histological confirm advanced metastatic adenocarcinoma stomach 3 . Have fail least 2 line chemotherapy 4 . Life expectancy least 12 week 5 . Eastern Cooperative Oncology Group Performance Status 0 1 6 . At least one measurable lesion beyond stomach ( large 10 mm diameter spiral CT scan ) 7 . Duration last therapy 6 week nitroso mitomycin 8 . More 4 week operation radiotherapy cytotoxic agent 9 . Adequate hepatic , renal , heart , hematologic function 1 . Pregnant lactate woman 2 . History malignancy except cure basal cell carcinoma skin carcinoma insitu uterine cervix 3 . Hypertension unable control within normal level follow treatment antihypertension agent ( systolic blood pressure &gt; 140 mmHg , diastolic blood pressure &gt; 90 mmHg ) 4 . Any factor influence usage oral administration 5 . Evidence central nerve system metastasis 6 . Intercurrence one following : coronary artery disease , arrhythmia , heart failure 7. proteinuria ≥ ( + ) 8. International Normalized Ratio &gt; 1.5 activate partial thromboplastin time &gt; 1.5 × Upper limit normal（ULN） 9 . Certain possibility gastric intestine hemorrhage 10 . Less 4 week last clinical trial 11 . Prior VEGFR inhibitor treatment 12 . Disability serious uncontrolled intercurrence infection Objective evidence previous current pulmonary fibrosis history , interstitial pneumonia , Pneumoconiosis , radiation pneumonitis , drugrelated pneumonia , Pulmonary function damage seriously etc</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Gastric Cancer</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Dose titration</keyword>
</DOC>